Blue Yonder Recognized as a Leader in Nucleus Research Supply Chain Planning Value Matrix 2022
Leadership ranking is attributed to Blue Yonder’s ability to deliver value to customers through the…
Leadership ranking is attributed to Blue Yonder’s ability to deliver value to customers through the…
Sales and Technology Veteran Recognized for His Success Ensuring Top-Line Growth and Market Expansion AUSTIN,…
Company delivers the first platform that allows any business to embed a mortgage at the…
AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a cloud-based,…
Castellum, Inc. Announces Accretive Restructuring and $1.5 Million Investment for Uplisting from Crom Cortana Fund…
MIAMI, April 07, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
At week 2, FMX114 demonstrated a statistically significant reduction in both absolute and percent change…
Propella to Receive Upfront Payment, Regulatory and Sales Milestones, and Royalties Phase 2 Study of…
THE WOODLANDS, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology…
Data to be featured in an oral presentation on April 12, 2022 at 3:35pm (CDT)…
SOUTH SAN FRANCISCO, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
WEST CHESTER, Pa., April 07, 2022 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
The abstract was accepted by ACOG and will be presented from May 4th – May…